Retractable hardtop

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retrieved on: 
Friday, September 29, 2023
General Health, Health, Medical Supplies, Medical Devices, Injection, Maintenance, IV, Injury, RVP, Risk, NYSE, Bloodstream infections, Safety, Syringe, Medical device, Online shopping, Retractable hardtop

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

Key Points: 
  • Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
  • The dividends cover the period beginning July 1, 2023 through September 30, 2023.
  • The dividends will be paid on October 20, 2023 to shareholders of record as of the close of business on October 10, 2023.
  • Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle.

Retractable Technologies, Inc. Results for the Period Ended June 30, 2023

Retrieved on: 
Monday, August 14, 2023
Medical Supplies, Medical Devices, Health, Infectious Diseases, General Health, Pharmaceutical, Government, Travel, Retractable hardtop, Investment, Comparison, Marketing, Security (finance), Cryptocurrency, Tourism, Music

Retractable reports the following results of operations for the three and six months ended June 30, 2023 and 2022, respectively.

Key Points: 
  • Retractable reports the following results of operations for the three and six months ended June 30, 2023 and 2022, respectively.
  • Comparison of Three Months Ended June 30, 2023 and June 30, 2022
    Domestic sales accounted for 91.6% and 66.7% of the revenues for the three months ended June 30, 2023 and 2022, respectively.
  • Domestic unit sales were 87.9% of total unit sales for the three months ended June 30, 2023. International revenues decreased approximately 86.0% predominately due to fewer international vaccination-related sales.
  • Comparison of Six Months Ended June 30, 2023 and June 30, 2022
    Domestic sales accounted for 67.1% and 60.1% of the revenues for the six months ended June 30, 2023 and 2022, respectively.

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retrieved on: 
Friday, June 30, 2023
Medical Devices, Manufacturing, Other Manufacturing, Health, Medical Supplies, Injection, Maintenance, IV, Injury, RVP, Risk, NYSE, Bloodstream infections, Safety, Syringe, Medical device, Online shopping, Retractable hardtop

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

Key Points: 
  • Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
  • The dividends cover the period beginning April 1, 2023 through June 30, 2023.
  • The dividends will be paid on July 20, 2023 to shareholders of record as of the close of business on July 10, 2023.
  • Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle.

Retractable Technologies, Inc. Results for the Period Ended March 31, 2023

Retrieved on: 
Monday, May 15, 2023
Medical Devices, COVID-19, Health, Pharmaceutical, Medical Supplies, Government, Redmi Note 11, Retractable hardtop, Investment, Comparison, Vaccination, Bank statement, Pharmaceutical industry, Security (finance), Cryptocurrency

During the first quarter of 2023, Retractable increased its investment in U.S. government-backed mutual funds by approximately $9.0 million and restructured its investments in equity securities by approximately $6.0 million.

Key Points: 
  • During the first quarter of 2023, Retractable increased its investment in U.S. government-backed mutual funds by approximately $9.0 million and restructured its investments in equity securities by approximately $6.0 million.
  • These actions were a significant factor in the decreased cash position in the first quarter of 2023.
  • Retractable reports the following results of operations for the three months ended March 31, 2023 and 2022, respectively.
  • Comparison of Three Months Ended March 31, 2023 and March 31, 2022
    Domestic sales accounted for 49.3% and 58.0% of the revenues for the three months ended March 31, 2023 and 2022, respectively.

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retrieved on: 
Friday, March 31, 2023
General Health, Health, Medical Supplies, Injection, Maintenance, IV, Injury, RVP, Risk, NYSE, Bloodstream infections, Safety, Syringe, Medical device, Online shopping, Retractable hardtop

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

Key Points: 
  • Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
  • The dividends cover the period beginning January 1, 2023 through March 31, 2023.
  • The dividends will be paid on April 20, 2023 to shareholders of record as of the close of business on April 10, 2023.
  • Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle.

Wisson Robotics launches NimboTM Series pliable robotic manipulators to empower service industries

Retrieved on: 
Friday, March 17, 2023
Maintenance, Human, Orion, Ageing, Unmanned aerial vehicle, App Store (iOS/iPadOS), K1000, Centaur, Chemical industry, PTZ, Pneumatics, Draco, Series, Dust, Lifting, Ultra, Joint, Observation, UAV, Robotics, Electromagnetic radiation, Environment, Retractable hardtop, DOF Subsea, Safety, Heavy equipment, Machine shop, Computer data storage, Electric motor, Surveying, Cobot

The Wisson NimboTM series manipulators were developed on the proprietary Pliabot® platform technology, following a completely distinctive core structure from conventional motor-based robotic manipulators.

Key Points: 
  • The Wisson NimboTM series manipulators were developed on the proprietary Pliabot® platform technology, following a completely distinctive core structure from conventional motor-based robotic manipulators.
  • Due to material-level and structure-level innovations, Wisson NimboTM series pliable manipulators could achieve over 1:1 payload-to-weight ratio, and topping at 3:1 maximum ratio at certain postures, approaching and surpassing human-arm capacities.
  • Wisson NimboTM series pliable manipulators were developed based on the proprietary pliable core technologies, the Pliabot® high-performance bionic muscles, the SlimDriveTM high-precision pneumatic controllers, and the SlimEngineTM flexible intelligent algorithm platform.
  • The Wisson Orion series flying pliable robots are comprised of retractable pliable manipulators mounted underneath commercial drones, forming complete solutions for remote aerial operations with direct physical interactions.

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retrieved on: 
Wednesday, December 28, 2022
Medical Supplies, Medical Devices, Health, Hospitals, Other Health, General Health, Bloodstream infections, Injury, Transport, Syringe, Injection, Risk, NYSE, Safety, Luer, Maintenance, RVP, IV, Medical device, Retractable hardtop

Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

Key Points: 
  • Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
  • The dividends cover the period beginning October 1, 2022 through December 31, 2022.
  • The dividends will be paid on January 20, 2023 to shareholders of record as of the close of business on January 10, 2023.
  • Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle.

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2022

Retrieved on: 
Monday, November 14, 2022
General Health, Medical Devices, Hospitals, Health, Medical Supplies, Injection, Injury, Government, Luer, Safety, IV, Transport, Maintenance, Bloodstream infections, Syringe, Comparison, Risk, Medical device, Music, Forming (metalworking), Security (finance), Retractable hardtop

Retractable reports the following results of operations for the three and nine months ended September 30, 2022 and 2021, respectively.

Key Points: 
  • Retractable reports the following results of operations for the three and nine months ended September 30, 2022 and 2021, respectively.
  • Comparison of Three Months Ended September 30, 2022 and September 30, 2021
    Domestic sales accounted for 39.9% and 93.7% of the revenues for the three months ended September 30, 2022 and 2021, respectively.
  • Domestic unit sales were 29.0% of total unit sales for the three months ended September 30, 2022. International revenues increased approximately 507.4% predominantly due to international vaccination campaigns.
  • Domestic unit sales were 40.7% of total unit sales for the nine months ended September 30, 2022.

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retrieved on: 
Friday, September 30, 2022
General Health, Other Health, Hospitals, Health, Medical Supplies, Injection, Injury, Safety, IV, Risk, NYSE, Luer, U.S. Securities and Exchange Commission, RVP, Private Securities Litigation Reform Act, Maintenance, Forward-looking statement, Transport, Board of directors, Syringe, Board, Bloodstream infections, Medical device, Retractable hardtop

Retractable Technologies, Inc. (Retractable) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.

Key Points: 
  • Retractable Technologies, Inc. (Retractable) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $19,061.25, respectively.
  • The dividends cover the period beginning July 1, 2022 through September 30, 2022.
  • The dividends will be paid on October 21, 2022 to shareholders of record as of the close of business on October 11, 2022.
  • Retractable manufactures and markets VanishPoint and Patient Safe safety medical products and the EasyPoint needle.

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2022

Retrieved on: 
Monday, August 15, 2022
General Health, Other Health, Hospitals, Health, Medical Supplies, U.S. Securities and Exchange Commission, Risk, Income, Injection, Forward-looking statement, IV, Private Securities Litigation Reform Act, Luer, Government, Injury, Syringe, COVID-19, Safety, Comparison, Maintenance, Bloodstream infections, Online gambling, Animal, Music, Health insurance, Security (finance), Renewable energy, Retractable hardtop

Retractable reports the following results of operations for the three and six months ended June 30, 2022 and 2021, respectively.

Key Points: 
  • Retractable reports the following results of operations for the three and six months ended June 30, 2022 and 2021, respectively.
  • Comparison of Three Months Ended June 30, 2022 and June 30, 2021
    Domestic sales accounted for 66.7% and 94.3% of the revenues for the three months ended June 30, 2022 and 2021, respectively.
  • Domestic unit sales were 51.4% of total unit sales for the three months ended June 30, 2022. International revenues increased approximately 97.5% predominately due to international vaccination campaigns.
  • Domestic unit sales were 46.5% of total unit sales for the six months ended June 30, 2022.